SEC Filings
Profound Medical Signs Co-Education Deal With Telix To Pair PSMA-PET Imaging With TULSA-PRO
Profound is also developing PSMA-PET–MR image fusion for a planned future release of its Treatment Delivery Console software.
Profound Medical (PROF) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
Profound is also developing PSMA-PET–MR image fusion for a planned future release of its Treatment Delivery Console software.
Earnings
The company's preliminary, unaudited figures point to 85% to 89% growth from a year ago, with gross margin again expected above 70%.